Global CNS Therapeutic Market Analysis


  • Type: Therapeutics Area
  • Published : March 2021
  • Region: Worldwide
  • Country: Other
  • Report ID : 260

  • Format: PPT, PDF


Global Central Nervous System Therapeutic Market: Segmented by Region (North America, Europe, Asia-Pacific, Latin America, and Middle-East and Africa) – Industry Analysis, Size, Share, Trends and Forecast, 2019-2028


Report Overview

The global Central Nervous System (CNS) therapeutics market size stood at around USD 91.67 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

The global CNS therapeutics market is likely to be driven by the rise in ageing population. According to the National Institute on Aging, almost 524 million individuals, approximately 8% of the global population, were above the age of 65 in 2010. This number is expected to reach 1.5 billion, which is almost 16% of the global population, by 2050. The rate of incidence of CNS diseases increases with advancing age.  Governments as well as non-government organizations across the globe are taking various initiatives to raise awareness about CNS disorders. Organizations are also raising funds to support clinical research & development for better treatment of the disease.

Market Drivers

The global CNS therapeutics market is likely to be driven by the high prevalence of these disorders, and growth in the awareness about CNS therapeutics diseases. Unmet needs for the treatment of CNS disease are high. In order to fuel research and clinical developments in these disorders, governments, non-profit organizations, and pharmaceutical and biotechnology companies across the globe have allocated and increased their research funding budget over a period of time. This factor is expected to fuel the market growth during the forecast period.

Patent expiry of drugs, however, is likely to affect the overall market growth during the forecast period.

Major Central Nervous System Disease

The mental health segment dominated the market in 2019 and is expected to continue its dominance throughout the forecast period. An increasing number of patients with mental disorders, extensive R&D, a rising number of rehabilitation facilities, and the introduction of novel treatment procedures are prime factors propelling growth. R&D and the introduction of novel and advanced solutions for neurological imaging are spurring the growth of the neurovascular diseases segment.

1. Global Central Nervous System Therapeutics Market Overview…………….
A. Market Size
2. Market Growth Drivers…………………………………………………………………..
A. Increasing prevalence of CNS disorder
B. Patent cliff
3. Major Central Nervous System Diseases…………………………………………………..
A. Neurovascular
B. Trauma
C. Mental Health
D. Degenerative Disorder
E. Infectious Disease
F. Cancer
4. Central Nervous System Therapeutics Market Segmentation…………………
A. Geography
I. North America Market Analysis
II. Europe Market Analysis
III. Asia-Pacific Market Analysis
IV. Middle-East and Africa Market Analysis
V. Latin America Market Analysis
5. Central Nervous System Major Products Market Share………………………
A. Key Findings
B. Market Analysis, Insights and Forecast – By Drug Type
6. Competitive Landscape…………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles…………………………………………………………………..
A. Pfizer Company overview, Product & Services, Strategies & Financials
B. Eli Lilly Company overview, Product & Services, Strategies & Financials
C. Biogen Company, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape…………………………………
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth………………………………………………………
A. New Trends and Development of Central Nervous System drug market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Region:

United States and Europe represent large markets worldwide with a combined share of 70% of the market. This can be attributed to factors such as the rising number of reported cases of depression & anxiety and the high adoption of advanced therapeutics. In addition, awareness campaigns and conferences about diagnosis & treatment of CNS diseases, including mental diseases, organized by leading pharma companies and/or rehabilitation centers are expected to increase the number of patients opting for early diagnosis.

Asia Pacific is expected to exhibit the highest growth rate due to the high prevalence of neurodegenerative diseases, rapidly increasing awareness regarding mental health, and improving healthcare facilities. Countries such as India and China have several nongovernment organizations that offer affordable treatments to people with Alzheimer’s and Parkinson’s disease.

China ranks as the fastest growing market with a CAGR of 7.3% over the analysis period supported by factors such as changing social structures and increased risk of developing psychiatric disorders such as schizophrenia, sleep disorders, depression and anxiety; growing literacy rates, improved awareness and gradual reduction in the stigma associated with neurological disorders; and government policy led development of healthcare delivery systems.

Middle East and Africa is expected to experience lucrative growth with increasing access to advanced therapeutic options owing to initiatives by the United Nations Programme on HIV/AIDS (UNAIDS) and other non-governmental organizations for the treatment of NeuroAIDS which affects more than 11 million people in sub-Saharan Africa.

Top Major Players

Companies currently dominating the market are Pfizer, Inc.; Biogen, Inc.; Eli Lilly and Company; Johnson & Johnson Services, Inc.; Otsuka America Pharmaceutical, Inc.; Merck & Co., Inc.; AstraZeneca; Novartis AG; Teva Pharmaceutical Industries Ltd.; and Shire Plc. These players are investing heavily in R&D to create a strong pipeline of drugs aimed at delivering improved patient care at low costs.

The majority of companies adopt strategies such as regional expansion, enhancement of product portfolio, and development of advanced diagnostic methods to increase the success rate of treatment.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements